Random mutations in the SARS-CoV-2 pathogen’s genome help researchers track the spread and transmission of COVID-19, the disease it causes.

An increase in confirmed infections, particularly in Italy, Iran, and South Korea, has led to heightened measures to prevent the spread of the virus SARS-CoV-2.

Emerging data as well as knowledge from the SARS and MERS coronavirus outbreaks yield some clues as to why SARS-CoV-2 affects some people worse than others.

Researchers look to messenger RNA encased in nanoparticles, DNA plasmids, molecular clamps, and other approaches as they rush to design a vaccine against the new coronavirus.

Scientists’ latest understanding of the facts, the suspicions, and the discounted rumors of SARS-CoV-2’s transmission from person to person

Read The Scientist’s latest coverage of SARS-CoV-2’s spread and researchers’ efforts to develop diagnostics, vaccines, and therapies to combat the disease, COVID-19.

Liu Zhiming is the eighth frontline health-care worker to die from COVID-19, and hundreds more have been infected.

Under careful watch of the World Health Organization, doctors will test a range of COVID-19 therapies, including HIV and flu antivirals, blood plasma infusions, and traditional Chinese medicines.

The National Institute of Allergy and Infectious Diseases releases a series of images that offer a close up look at the novel coronavirus SARS-CoV-2.